IP Library Granted Patent US 8,906,667
Granted Patent B2
US 8,906,667 · App. 12/439,497 · Granted Dec 9, 2014

Increasing NADPH-dependent products

Inventors: Ka-Yiu San (Houston, TX); George Bennett (Houston, TX); Henry Lin (Houston, TX); Irene Martinez (Houston, TX); Jiangfeng Zhu (Houston, TX)
Assignee: William Marsh Rice University
C07K14/315C12N15/70A61K38/484C07K14/30C07K14/33C07K14/395C12N9/0006C12P17/06C12P23/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,906,667
App. No.
12/439,497
Granted
Dec 9, 2014
Kind
B2
Abstract

A method of increasing cellular NADPH levels by expressing one or more genes that encode an enzyme that causes the production of NADPH. The system is combined with other enzymes that require NADPH, thus improving the overall yield of the desired product.

Claims (14)

1. An engineered Escherichia coli comprising:

a. a deleted gapA (ΔgapA) gene;

b. an overexpressed DNA encoding gapC (an NADP-dependent D-glyceraldehyde-3-phosphate dehydrogenase (NADP-GAPDH)); and

c. an overexpressed DNA encoding:

i. a β-ketothiolase, an acetoacetyl-CoA reductase and a polyhydroxybutyric acid (PHB) synthase, wherein said cell produce 5-10 fold more PHB than a control cell lacking a) and b); or

ii. a cyclohexanone monooxygenase, wherein said cell produces about 1.7 fold more caprolactone than a control cell lacking a) and b), or

iii. a phytoene synthase, a geranylgeranyl pyrophosphate (GGDP) synthase, and phytoene desaturase, wherein said cell produces about 2.5 fold more lycopene than a control cell lacking a) and b).

2. The Escherichia coli of claim 1 , wherein said DNA encoding said NADP-GAPDH is stably incorporated into a genomic insertion site in said cell.

3. The Escherichia coli of claim 1 , said NADP-GAPDH having the amino acid sequence of SEQ ID NO. 1.

4. Escherichia coli of claim 2 , said NADP-GAPDH having the amino acid sequence of SEQ ID NO. 1.

5. An engineered Escherichia coli comprising:

a. a deleted gapA (ΔgapA) gene;

b. an overexpressed DNA encoding gapC (an NADP-dependent D-glyceraldehyde-3-phosphate dehydrogenase (NADP-GAPDH)), wherein said gapC is the gene encoding the protein having amino acid sequence of SEQ ID NO. 1; and

c. an overexpressed DNA encoding an NADPH utilizing enzyme, wherein said cell produces at least 1.7 fold more product from said NADPH utilizing enzyme than a control cell lacking a) and b).

Assignments (2)
CONFIRMATORY LICENSE Recorded May 17, 2012
From: RICE UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 028225/0983 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2009
From: SAN, KA-YIU; BENNETT, GEORGE; LIN, HENRY; MARTINEZ, IRENE; ZHU, JIANGFENG
To: RICE UNIVERSITY
Reel/Frame 022615/0226 →
Continuity (2)
Provisional Application 60823829 · Aug 29, 2006
Related Publication 20100009418A1 · Jan 14, 2010